Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Declining mortality in coronary heart disease

R I Levy

    Arteriosclerosis (Dallas, Tex.)
    |September 1, 1981
    PubMed
    Summary

    Cardiovascular disease mortality has significantly declined since 1968 due to improved treatments and lifestyle changes like smoking cessation and hypertension control. This trend is observed across all demographics, highlighting effective prevention and medical advancements.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chyloperitoneum in a peritoneal dialysis patient.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
    Same author

    Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

    JAMA·2000
    Same author

    Primordial prevention of cardiovascular disease risk factors: panel summary.

    Preventive medicine·2000
    Same author

    Dedicated research institute keeps Wyeth-Ayerst focused on women's health.

    Journal of women's health·1997
    Same author

    Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

    JAMA·1994
    Same author

    A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin.

    Circulation·1993

    Area of Science:

    • Cardiovascular Medicine
    • Public Health
    • Epidemiology

    Background:

    • A significant and sustained decline in cardiovascular disease (CVD) mortality, particularly from coronary heart disease and stroke, has been observed in the United States since 1968.
    • This mortality reduction is a real phenomenon, consistently seen across all age, sex, and racial groups.

    Purpose of the Study:

    • To identify and analyze the contributing factors behind the unprecedented decline in cardiovascular disease mortality.
    • To assess the roles of advancements in medical treatment and primary prevention strategies.

    Main Methods:

    • Review of epidemiological data on cardiovascular disease mortality trends.
    • Analysis of temporal associations between mortality declines and the adoption of new medical interventions and public health initiatives.
    • Examination of changes in cardiovascular risk factor prevalence and management.

    Main Results:

    • The decline in coronary heart disease mortality is linked to advancements in acute coronary care, pharmaceuticals, surgical procedures (e.g., coronary artery bypass), and noninvasive diagnostics.
    • Mortality trends correlate with increased awareness and modification of risk factors, including smoking cessation, hypertension control, dietary changes, and cholesterol reduction.

    Conclusions:

    • Both enhanced medical treatments and primary prevention efforts, particularly lifestyle modifications, have significantly contributed to the reduction in cardiovascular disease mortality.
    • The observed decline underscores the effectiveness of a multi-faceted approach involving both clinical interventions and public health strategies in combating cardiovascular disease.

    Related Experiment Videos